O'Brien, F. E., Moloney, G. M., Scott, K. A., O'Connor, R. M., Clarke, G., Dinan, T. G., . . . Cryan, J. F. (2015). Chronic P‐glycoprotein inhibition increases the brain concentration of escitalopram: Potential implications for treating depression. Pharmacol Res Perspect.

O'Brien, Fionn E., Gerard M. Moloney, Karen A. Scott, Richard M. O'Connor, Gerard Clarke, Timothy G. Dinan, Brendan T. Griffin, and John F. Cryan. "Chronic P‐glycoprotein Inhibition Increases the Brain Concentration of Escitalopram: Potential Implications for Treating Depression." Pharmacol Res Perspect 2015.

O'Brien, Fionn E., et al. "Chronic P‐glycoprotein Inhibition Increases the Brain Concentration of Escitalopram: Potential Implications for Treating Depression." Pharmacol Res Perspect 2015.